Skip to main content
EYENational Vision Holdings, Inc.Sell5.9·$17.94
SellHigh Confidence
Investment thesis

National Vision offers a compelling value setup — a PEG of 0.14 and a forward multiple of 15.2x against a recent earnings track record featuring 46% average upside surprise — but is weighed down by a confirmed technical downtrend and 20% short interest. The risk/reward geometry of roughly 42% upside against 7% downside at nearly 6-to-1 creates an asymmetric opportunity if business momentum can overcome the bearish technical and sentiment overhang.

Thesis pillars

  • Strong Recent Earnings Execution↓Deteriorating
  • Cash Conversion Quality Gap→Stable
  • Compelling Valuation Very Low Peg↓Deteriorating
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Mar 4, 2026· older than 90 days

Full reasoning →

Open full analysis

National Vision Holdings, Inc. (EYE) Stock Analysis

Recovery setup · Inst Constrain edge

SellVALUE-TRAP 1/5GrowthShortHigh Confidence

Consumer Cyclical · Specialty Retail

Earnings in 6 days (2026-11-12). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Multiple concerning factors at $17.94: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5.

National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations), Eyeglass World (122 locations), and two Vista Optical host brands — throughout the United States. The company sells eye exams, eyeglasses, and contact lenses,... Read more

$17.94+33.4% A.UpsideScore 5.9/10#7 of 23 Specialty Retail
QualityF-score8 / 9FCF yield3.43%
Stop $16.68Analyst target $23.93(−13% haircut)A.R:R 2.2:1
Analyst consensus$27.50+53.3%10 analysts with price targets
$23.93Analyst target
$17.94price
$27.50mean
$35

Sell if holding. Multiple concerning factors at $17.94: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5. Chart setup: Death cross but MACD improving, RSI 52. Score 5.9/10, high confidence.

Passes 6/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear, materials cycle peak clear). Fails on earnings proximity 6d<=7d. Suitability: speculative.

10-K grounded · weekly refresh

About National Vision Holdings, Inc.

About National Vision Holdings, Inc.

National Vision Holdings operated 1,250 retail optical stores across four brands at fiscal year-end January 3, 2026, with America's Best at 1,057 locations forming the core owned brand and Eyeglass World at 122 locations as the secondary format. Managed care insurance billing represented 42% of revenues from continuing operations in 2025, and omni-channel plus e-commerce platforms contributed approximately 7% of net revenue. The company opened 33 new stores in fiscal 2025 and targets 30 to 35 openings in fiscal 2026, with plans to reaccelerate to roughly 60 openings per year beginning 2028 for a total of approximately 240 new stores through 2030.

National Vision earns revenue through direct retail sales of frames and lenses, contact lens sales, and eye exam services provided by employed or contracted optometrists. The Eyecare Club subscription program — with approximately 1.3 million active members at January 3, 2026 — offers two eye exams per year plus a 10% discount for a one-time fixed multi-year fee, driving repeat traffic and contact lens refills. Supply is concentrated: EssilorLuxottica holds the sole and exclusive right to supply certain eyeglass lenses to National Vision under an agreement that runs through May 2028, while CooperVision manufactures the company's private label contact lens brands (Sofmed and Natural Eyes HydraWear). New store economics target a cash investment of $0.4 million to $0.6 million per location, with fifth-year sales of $1.5 million to $1.7 million and capital payback in three to five years. Competition spans independent optical retailers (roughly half the industry), mass merchants, warehouse clubs, specialty chains, and online contact lens sellers.

Show full overview

National Vision's managed care exposure at 42% of continuing operations revenues creates a dependency on vision insurance network admissions. The 10-K acknowledges that competition in managed care is based on price and network density and that the company may face heightened challenges to be admitted or to maintain status in managed care provider networks. Separately, the EssilorLuxottica sole-supply lens agreement expires in May 2028, creating a renegotiation event that could affect lens cost structure if renewal terms shift — a risk that compounds the managed care exposure since lens margin is a key driver of the value proposition to insurance-paying customers.

See also: Consumer Cyclical · Specialty Retail

From National Vision Holdings, Inc.'s most recent 10-K filing, extracted June 10, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

No fresh coverage since Aug 12, 2026

Recent Developments — National Vision Holdings, Inc.

Latest item Aug 12, 2026 · Generated 2026-11-05T11:39:29Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 12, 20266d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Positive insider activity
Risks
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3)
Sector modifier (Consumer Cyclical): -1.5
Earnings in 6 days (event risk)

Key Metrics

P/E (TTM)28.9
P/E (Fwd)14.9
Mkt Cap$1.4B
EV/EBITDA11.2
Profit Mgn2.5%
ROE5.8%
Rev Growth2.5%
Beta0.93
DividendNone
Analysts with ratings15

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.04bullish
IV89%elevated
Max Pain$15-16.4% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
2.0
Support Resistance
2.4
Bollinger
2.9
Gap
4.0

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
1.9
Growth Rank
2.6
Value Rank
3.1
GatesEARNINGS PROXIMITY 6d<=7dDeath cross (50MA < 200MA)Momentum 6.4>=5.5A.R:R 2.2 ≥ 1.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Speculative
RSI
52 · Neutral
↑ 20D MA↑ 50D MA↓ 200D MADEATH CROSSSupport $14.92Resistance $18.87

Price Targets

$17
$24
A.Upside+33.4%
A.R:R2.2:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! EARNINGS_PROXIMITY:6d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-12 (6d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is EYE stock a buy right now?

Sell if holding. Multiple concerning factors at $17.94: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5. Chart setup: Death cross but MACD improving, RSI 52. Prior stop was $16.68. Score 5.9/10, high confidence.

What is the EYE stock price target?

Analyst target: $23.93 (+33.4% upside). Prior stop was $16.68. Stop-loss: $16.68.

What are the risks of investing in EYE?

V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5; Earnings in 6 days (event risk).

Is EYE overvalued or undervalued?

National Vision Holdings, Inc. trades at a P/E of 28.9 (forward 14.9). TrendMatrix value score: 8.0/10. Verdict: Sell.

What do analysts say about EYE?

15 analysts rate EYE, with a consensus score of 4.1/5. 10 analysts publish price targets averaging $28.

What does National Vision Holdings, Inc. do?National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations),...

National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations), Eyeglass World (122 locations), and two Vista Optical host brands — throughout the United States. The company sells eye exams, eyeglasses, and contact lenses, with managed care insurance billing representing 42% of revenues from continuing operations in 2025. EssilorLuxottica holds the sole and exclusive right to supply certain eyeglass lenses under a contract running through May 2028.

Related stocks: BWMX (Betterware de Mexico, S.A.P.I. ) · BOBS (Bob's Discount Furniture, Inc.) · MUSA (Murphy USA Inc.) · FIVE (Five Below, Inc.) · BBWI (Bath & Body Works, Inc.)
Home › Stocks › EYE

Latest news

Latest News

Investing.com204d ago
TradingView176d agoEarnings
Seeking Alpha176d agoEarnings
Moomoo176d ago
MSN176d ago
Yahoo Finance176d agoEarnings
GuruFocus176d agoEarnings
Investing.com176d agoEarnings
Marketscreener.com176d agoEarnings
Marietta Daily Journal176d agoEarnings
The Rome News-Tribune176d agoEarnings
10TV176d agoEarnings
KING5.com176d agoEarnings
KTVB176d agoEarnings
WKYC176d agoEarnings
Investing.com Canada85d ago
Marketscreener.com85d agoEarnings
Quiver Quantitative85d agoEarnings
TradingKey85d ago
The Rome News-Tribune85d agoEarnings
Loading more...